Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Asceneuron raised $100m in Series C funding led by Novo Nordisk

Asceneuron raised $100m in Series C funding led by Novo Nordisk

Biotech Health services Pharma

Switzerland

Netherlands

Denmark

United States

France

Investments

04 July 2024

Share:

Asceneuron (company)

Switzerland

Biotech Health services Pharma

Total investments received (USD): 100m

Round value (USD): 100m

Round investors: Merck Ventures Novo A/S OrbiMed Advisors Sofinnova Partners JJDC - Johnson & Johnson SR One

Company: Asceneuron

Industry: Biotech Health services Pharma

Related deals

Alentis Therapeutics raised $181m in Series D funding co-led by OrbiMed, Novo Holdings, and Jeito Capital

Biotech Health services Manufacturing

Switzerland

France

United States

Denmark

United Kingdom

Investments 01 November 2024

Alys Pharmaceuticals raised $100 million seed with Medicxi

Health services Manufacturing Pharma

Switzerland

United Kingdom

Investments 04 February 2024

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top